Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Text Message Reminders for Completion of HPV Vaccination Amongst Adolescent Girls in Uganda

Trial Status: active

This clinical trial tests the feasibility and efficacy of using text message reminders for completion of human papillomavirus (HPV) vaccination series in adolescent girls in Uganda. Sub-Saharan Africa has the highest cervical cancer mortality rates in the world and cervical cancer is the leading female cancer in Uganda. HPV is the principal cause of cervical cancer, making vaccination the single most important primary preventive measure. Text messages act as both a reminder for the needed doses as well as a vehicle for providing educational information about the vaccine. Using a text message reminder system may increase timeliness of HPV vaccination in adolescent girls in Uganda.

Have a question?
We're here to help

Chat with us: LiveHelp
Call us: 1-800-4-CANCER
(1-800-422-6237)

Which trials are right for you?

Use the checklist in our guide to gather the information you’ll need.